Genetic testing is helping doctors identify rare diseases earlier, opening the door to treatment options before symptoms ...

Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.

The FDA is due to rule by August 23 on Ultragenyx’s application for DTX401, a one-time gene therapy for von Gierke disease.

Much of how genetic risk leads to disease has remained hidden. In many cases, genetic variants linked to disease do not act ...

The patient's genetic disorder causes frequent seizures and developmental delays. His progress, along with that of another boy who received a similar personalized treatment, highlights the promise—and ...

Children with rare genetic disorders often face years of uncertainty before receiving a diagnosis, leaving families without clear information about disease progression, treatment options, prognosis, ...

Alzheimer's disease is the most common form of dementia worldwide, and its development is influenced by a combination of ...

Rare genetic disorders affect more than 300 million people worldwide, with children making up 70% of those impacted, according to EURORDIS. These conditions often go undiagnosed for years due to ...

Influencer Michiel Vandeweert, who had a rare disorder, has died. He was 28. His death was shared by Flemish news broadcast ...

A single, untargeted proteomics test for rare genetic diseases has been developed. A research team from the University of Melbourne (Australia) and Murdoch Children’s Research Institute (Victoria, ...

Michiel Vandeweert, a Flemish content creator, shared his life living with progeria, a rare, progressive genetic disorder that causes children to age rapidly ...

The Social Security Administration added 14 rare diseases to a fast-track disability program that can help qualifying ...